Details for Patent: 9,268,909
✉ Email this page to a colleague
Which drugs does patent 9,268,909 protect, and when does it expire?
Patent 9,268,909 protects ABILIFY MYCITE KIT and is included in one NDA.
This patent has twenty-one patent family members in seventeen countries.
Summary for Patent: 9,268,909
Title: | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
Abstract: | Provided is an apparatus, system, and method for stabilizing battery voltage of a battery device while optimizing power delivered to a receiver during communication of a broadcast packet. A logic circuit is configured to receive a broadcast packet having a predetermined number of bits for communication by a controller to a receiver located remotely from the controller, determine a number of cycles in which a sampled battery voltage is either greater than or less than or equal to a nominal battery voltage over a first subset of the predetermined number of bits of the broadcast packet and performs either a tune-up or a tune-down procedure based on the number of cycles counted in which the sampled battery voltage is not equal to the nominal battery voltage for more than one half of a total number of cycles counted. |
Inventor(s): | Jani; Nilay (San Jose, CA), Webb; Douglas (Los Altos, CA), Withrington; Jonathan (San Francisco, CA), Berkman; Jeffrey (Saratoga, CA), Li; Haifeng (Sunnyvale, CA) |
Assignee: | Proteus Digital Health, Inc. (Redwood City, CA) |
Application Number: | 14/435,240 |
Patent Claim Types: see list of patent claims | Use; Device; |
Patent landscape, scope, and claims: | More… ↓ |
Drugs Protected by US Patent 9,268,909
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-001 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-002 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-003 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-004 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-005 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-006 | Nov 13, 2017 | DISCN | Yes | No | 9,268,909 | ⤷ Try for Free | Y | METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,268,909
PCT Information | |||
PCT Filed | October 15, 2013 | PCT Application Number: | PCT/US2013/065041 |
PCT Publication Date: | April 24, 2014 | PCT Publication Number: | WO2014/062674 |
International Family Members for US Patent 9,268,909
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013331417 | ⤷ Try for Free | |||
Brazil | 112015008434 | ⤷ Try for Free | |||
Canada | 2888871 | ⤷ Try for Free | |||
China | 104737532 | ⤷ Try for Free | |||
Denmark | 2910013 | ⤷ Try for Free | |||
European Patent Office | 2910013 | ⤷ Try for Free | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |